加味过敏煎联合穴位贴敷治疗咳嗽变异性哮喘风邪犯肺证临床研究OA
Clinical Study on Modified Guomin Decoction Combined with Acupoint Application for Cough Variant Asthma with Pathogenic Wind Invading Lung Syndrome
目的:观察加味过敏煎联合穴位贴敷治疗咳嗽变异性哮喘(CVA)风邪犯肺证的临床疗效.方法:选取2024年1月—2025年6月长兴县中医院收治的80例CVA患者,按随机数字表法分为对照组和观察组各40例.最终观察组完成试验38例(剔除1例,脱落1例),对照组完成试验37例(剔除2例,脱落1例).对照组给予常规西药治疗,观察组在对照组基础上给予加味过敏煎联合穴位贴敷治疗,2组均治疗2周.评价2组临床疗效,比较2组中医证候评分、肺功能指标[第1秒用力呼气量(FEV1)、用力肺活量(FVC)、最大呼气流速(PEF)]、气道高反应性指标[嗜酸性粒细胞(EOS)、呼出气一氧化氮(FeNO)、血清免疫球蛋白-E(IgE)],并评估治疗安全性.结果:观察组总有效率为94.74%(36/38),高于对照组78.38%(29/37)(P<0.05).治疗后,2组各项症状评分及总分较治疗前降低(P<0.05),且观察组各项症状评分及总分低于对照组(P<0.05).治疗后,2组FEV1、FVC、PEF水平较治疗前提高(P<0.05),且观察组FEV1、FVC、PEF水平高于对照组(P<0.05).治疗后,2组EOS、IgE、FeNO水平较治疗前降低(P<0.05),且观察组EOS、IgE、FeNO水平低于对照组(P<0.05).2组不良反应发生率比较,差异无统计学意义(P>0.05).结论:加味过敏煎联合穴位贴敷治疗CVA患者疗效显著,可有效缓解患者临床症状,改善肺功能,减轻气道高反应性,且不良反应少.
Objective:To observe the clinical effect of modified Guomin Decoction combined with acupoint application for cough variant asthma(CVA)with pathogenic wind invading lung syndrome.Methods:A total of 80 CVA patients admitted to Changxing County Traditional Chinese Medicine Hospital from January 2024 to June 2025 were selected and divided into the control group and the observation group according to the random number table method,with 40 cases in each group.Finally,there were 38 cases in the observation group completed the trial(1 case excluded,1 case dropped out),and there were 37 cases in the control group completed the trial(2 cases excluded,1 case dropped out).The control group was treated with conventional western medicine,and the observation group was additionally treated with modified Guomin Decoction combined with acupoint application based on the treatment in the control group.Both groups were treated for two weeks.The clinical efficacy of the two groups was evaluated.The traditional Chinese medicine syndrome scores,lung function indexes[forced expiratory volume in one second(FEV1),forced vital capacity(FVC),peak expiratory flow rate(PEF)],airway hyperresponsiveness indexes[eosinophils(EOS),fractional exhaled nitric oxide(FeNO),serum immunoglobulin-E(IgE)]were compared between the two groups,and the treatment safety was evaluated.Results:The total effective rate was 94.74%(36/38)in the observation group,higher than that of 78.38%(29/37)in the control group(P<0.05).After treatment,the symptom scores and total scores of traditional Chinese medicine syndrome in the two groups were decreased when compared with those before treatment(P<0.05),and the symptom scores and total scores of traditional Chinese medicine syndrome in the observation group were lower than those in the control group(P<0.05).After treatment,the levels of FEV1,FVC,and PEF in the two groups were increased when compared with those before treatment(P<0.05),and the levels of FEV1,FVC,and PEF in the observation group were higher than those in the control group(P<0.05).After treatment,the levels of EOS,IgE,and FeNO in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of EOS,IgE,and FeNO in the observation group were lower than those in the control group(P<0.05).There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups(P>0.05).Conclusion:The combination use of modified Guomin Decoction and acupoint application has a significant curative effect on CVA patients,which can effectively alleviate the clinical symptoms of patients,improve lung function,and reduce airway hyperresponsiveness with fewer adverse reactions.
戴乐凤;毕华剑;王莉
长兴县中医院呼吸与危重症医学科,浙江 长兴 313100长兴县中医院呼吸与危重症医学科,浙江 长兴 313100长兴县中医院中药房,浙江 长兴 313100
医药卫生
咳嗽变异性哮喘风邪犯肺证加味过敏煎穴位贴敷中医证候评分肺功能气道高反应性
Cough variant asthmaPathogenic wind invading lung syndromeModified Guomin DecoctionAcupoint applicationTraditional Chinese medicine syndrome scoresLung functionAirway hyperresponsiveness
《新中医》 2026 (9)
42-49,8
浙江省中医药科技计划项目(2024ZL1040)
评论